News

FDA approves dasatinib for kids with Ph+ ALL
- Author:
- Jen Smith
The U.S.
News

Group proposes new grading systems for CRS, neurotoxicity
- Author:
- Jen Smith
A group of experts has proposed new consensus definitions and grading systems for cytokine release syndrome (CRS) and neurotoxicity related to...
News

Drug may be new option for transfusion-dependent β-thalassemia
- Author:
- Jen Smith
SAN DIEGO—Luspatercept can produce “clinically meaningful” results in transfusion-dependent adults with β-thalassemia, according to a speaker at...
News

Melflufen-dex proves active in multi-resistant MM
- Author:
- Jen Smith
SAN DIEGO—The combination of melflufen and dexamethasone demonstrated activity in patients with multi-resistant multiple myeloma (MM) in a phase 2...
News

Lymphodepletion improves efficacy of CAR T cells in HL
- Author:
- Jen Smith
SAN DIEGO—A phase 1 study suggests lymphodepletion can improve the efficacy of CD30-directed chimeric antigen receptor (CAR) T-cell therapy in...
News

Fludarabine deemed important for CD30.CAR T-cell therapy
- Author:
- Jen Smith
SAN DIEGO—Fludarabine is “very important” for lymphodepletion prior to CD30-directed chimeric antigen receptor (CAR) T-cell therapy, according to...
News

MetS after HSCT linked to CV events, second cancers
- Author:
- Jen Smith
SAN DIEGO—Patients who develop metabolic syndrome (MetS) after hematopoietic stem cell transplant (HSCT) have an increased risk of cardiovascular...
News

Inhibitor can improve symptoms of systemic mastocytosis
- Author:
- Jen Smith
SAN DIEGO—The KIT D816V inhibitor avapritinib can improve symptoms of systemic mastocytosis (SM), according to researchers. Patients treated with...
News

Algorithm uncovers DS in AML patients on IDH inhibitors
- Author:
- Jen Smith
SAN DIEGO—An algorithm has proven effective for identifying differentiation syndrome (DS) in patients taking ivosidenib or enasidenib, according...
News

Triplet demonstrates activity in relapsed/refractory MM
- Author:
- Jen Smith
SAN DIEGO—A three-drug combination produced “deep and durable” responses in patients with relapsed/refractory multiple myeloma (MM), according to...
News

Two-drug combo deemed ‘very promising’ for PMBCL
- Author:
- Jen Smith
SAN DIEGO—Nivolumab plus brentuximab vedotin may be a new treatment option for patients with relapsed/refractory primary mediastinal large B-cell...
News

Data support apixaban for cancer-associated VTE, doc says
- Author:
- Jen Smith
SAN DIEGO—Apixaban is as safe as, and more effective than, dalteparin for patients with cancer-associated venous thromboembolism (VTE), according...
News

Regimen provides survival benefit in PTCL
- Author:
- Jen Smith
SAN DIEGO—A newly approved treatment regimen provides a survival benefit over standard therapy for patients with CD30-positive peripheral T-cell...
News

FDA approves venetoclax for AML
- Author:
- Jen Smith
The U.S.
News

FDA approves glasdegib for AML
- Author:
- Jen Smith
The U.S.